Ligand · EBL
EBL · (2~{S})-10-[[5-chloranyl-2-[(3~{S},5~{R})-3-methyl-5-oxidanyl-piperidin-1-yl]pyrimidin-4-yl]amino]-2-cyclopropyl-3,3-bis(fluoranyl)-7-methyl-2,4-dihydro-1~{H}-[1,4]oxazepino[2,3-c]quinolin-6-one
EBL, (2~{S})-10-[[5-chloranyl-2-[(3~{S},5~{R})-3-methyl-5-oxidanyl-piperidin-1-yl]pyrimidin-4-yl]amino]-2-cyclopropyl-3,3-bis(fluoranyl)-7-methyl-2,4-dihydro-1~{H}-[1,4]oxazepino[2,3-c]quinolin-6-one (C26 H29 Cl F2 N6 O3, 547.0 g/mol), in…
- Component
- EBL
- Formula
- C26 H29 Cl F2 N6 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
EBL in 2 structures; the first of them:
- 7QK0 · Crystal structure of human BCL6 BTB domain in complex with compound 12a · EBL A201 · binds MET51, ALA52, CYS53, SER54, GLY55, TYR58, PHE89, GLN113 and 2 more
- 7QK0 · Crystal structure of human BCL6 btb domain in complex with compound 12A · EBL A201 · binds MET51, ALA52, CYS53, SER54, GLY55, TYR58, PHE89, GLN113 and 2 more
Residues it binds most
MET 2, ALA 2, CYS 2, GLN 2, GLU 2, GLY 2, PHE 2, SER 2, TYR 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.